<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 40 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page39.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=40">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 40 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 40</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=40"><img src="../thumb/40.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Central Nervous System - 1.3.1 / 1.3.2                                           2020-04 / 9
       Indications: Anx., alcohol.withdr.syndr.  Contraindications: Myasth.grav., infts.  Geriatr.pts./in pres.of debilitat.dis: 0,25 mg 2-3xdly. Dos range:
       (S5) TABS, [P/S] B/2.6/1343, 1344.  Side effects: Drowsin., oversedat., dizz., dry mouth, constip., de-  0,25-0,75 mg dly.in div.dos. incr. grad.if need.& tolerat.
       763500-003: 10 mg, 100, R193,98  press.of mood & affect, disorientat., confus., lethargy, atax., trem.,   (S5) SR TABS, [P/S] 29/2.6/0504, 0505, 0506.
       763519-006: 15 mg, 100, R274,30  incr./ decr. motor activ., N&V, bld.dyscras., hepat. dysfunct., paradox.  827185-006: 0,5 mg, 60, R318,77
       (S5) FORTE TABS, [P/S] A/2.6/774.  reacts.(discont.), floppy inft. syndr. (use dur.labour).  827193-009: 1 mg, 60, R596,67
       763527-009: 30 mg, 100, R439,06  Special precautions: Abuse potent., grad. withdr., eval.need for   827207-018: 2 mg, 60, R1 140,54
       Dosage: Indiv. & admin.for short per.only (2-4 wks)  cont.treatm.esp.if pt.is sympt. free, tot.durat.of treatm.not to exceed   Dosage: Admin.once dly. pref.in morn. Tabs. to be taken intact. Indiv.
       Resid.anx.syndr.in alcoh.withdr: 15-30 mg 3-4xdly.  8-12 wks. incl.taper.off process., imp.ren./hepat.funct., pulm. dis., anx.  bas.on sympt.severity & pt. respons. When high.dos req.incr.even.dos.
       Mild to mod.anx: 10-15 mg 3-4xdly.  with underly.depress.disords.  bef. dayt.dos. Use gen. principle of low.effect.dos.in elderly/debilit.
       Sev.anx: 15-30 mg 3-4xdly.    Drug interactions: Addit.risk of CNS depress. with other CNS depress.  Decr.dly.dos.by no more than 0,5 mg every 3 days.
       Contraindications: Prim.depress.disords/ psychos., pregn.,   Anx: Init: 1 mg dly in 1-2 dos. Dos range: 0,5-4 mg dly in 1-2 dos.
       breast feed.                  VALIUM, Roche [P/S]          Mix.anx./depress., anx. assoc.with depress: Init: 1 mg dly in
       Side effects: Bld.disords., hypersens.reacts.incl. anaphylact. reacts.,   Diazepam.  1-2 dos. Dos range: 0,5-4,5 mg dly in 1-2 dos.
       SIADH, hyponatraem., depress., unmask.depress., amnes., disinhibit.,   Indications: When disord.sev./diabl./subj.indiv.to extreme stress.   Panic disords: Init 0,5-1 mg at bedt.or 0,5 mg 2xdly. Dos range:
       euphoria, coma, suicide.ideat./attempt, paradoxic. reacts., drowsin.,   Anx.syndr.& adjunct.in anx./ excitat. assoc.with psych.disords., ad-  Mean maint.dos of 5-6 mg/day as sngl. dly.dos./2 div.dos. Indiv.
                                     junct.in reflex. musc.spasm due to loc.trauma & combat. spastic. aris.
       sedat., fatig., atax., dizzin., confus., syncope, headache, trem., slurr.  accord.to respons. with dos.increm.of no &gt;than 1 mg in dly dos.
       speech, vertigo, extrapyramid.sympts., convuls., seiz., coma, imp.at-  from spin.& supraspin.interneuron. damage  every 3-4 days.
                                     (S5) TABS, [P/S] B/2.6/1003, 1004.
       tent./concentrat., bal.disord., blurr. vis., hypotens., oed., resp.depress.,   Geriatrics: 0,5-1 mg dly.in 1-2 dos. Dos range: 0,5-1 mg dly grad.
       apnoea, worsen. of sleep apnoea & obstruct.pulm.dis., abuse potent.,   774472-007: 5 mg, 100, R438,93  incr.if need.& tol.
                                     774480-010: 10 mg, 100, R701,26
       tol.& depend., GI disturbs., jaund., skin rash, alopec., musc.weakn.,   Contraindications: Schizophren., concom. antiretrovir.protease in-
       libido changes, asthen., hypotherm.  Dosage: Treatm.durat.to be as short as poss.not exceed.2-3 mnths.  hibit./ketoconazole, safety & effic.not est.in childr.und.18 yrs., lact.
                                     incl.taper.-off period. Do not change to short act.benzodiazepines as
       Warnings & special precautions: Abuse potent., alcoh.& drug   intol., safety in pregn.& lactat.not est., dur.labour, effic. for longt.use
       abuse/hist.thereof, personality disords., convuls.more common with   withdr. sympt.poss.develop.  exceed.6 mnths. not est.
                                     Adults: Aveg.init.dos: 5-10 mg. Depend.on severity usual dos.5-20
       pre-exist. seiz.disords/meds.low.convuls.threshold, grad. withdr., re-  Side-effects: Decr.appet., psych.disords.incl. hallucinat./agitat.&
       assess.need for cont.treatm., sev. hepat. insuffic./encephalopathy,   mg dly. Max.sngl.dos not to exceed 10 mg.  rage, CNS effs., dizzin., headache, atax., memory/intellect.impairm.,
                                     Childr: 0,1-0,3 mg/kg bw dly.
       elderly/debilitat., pulm. dis.& limit.pulm.reserve, anx.accomp.by   dysarthr., incr.activ., trem., slurr.speech, blurr.vis., incr.IOP, GI/libido dis-
       underly. depress.disord., ren./hepat.dysfunct., ac. narr. angle glauc.,   (S5) INJ, [P/S] B/2.6/995. 10 mg/2 ml.  ords., abnorm.liv.funct., dermatit., musc.twitch./-weakn., enures., urin.
                                     Indications: Conscious sedat.in diagnost.& therapeut. intervent.
       period.bld.counts & LFT, where decr. in BP undesir., cont.lact., 15 mg   to relieve apprehens.& diminish recollect.thereof, anaesthes.pre-  freq./retent., menstr.irregular., sex.dysfunct., fatig., jaund., weight
       cont.tartraz., cross. placenta, excret.in breast milk.  medicat., excitat.states assoc.with psych.disords., anti-convuls. in   chang., hyperprolactinaem., hypoman., man., hostilit., psychomot.
       Drug interactions: Addit CNS depress.eff.with other CNS depress.,   status epileptic.& other convuls.states incl. tetan., eclamps.seiz.,   hyperactiv., dyston., auton.nerv.syst.imbal., hepatit., jaund., angi-
       theophyll./aminophyll.reduc. sedat.effs.,  musc.relaxat.as for tabs.  oed., incont., periph.oed.
       TRANQIPAM, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  774510-005: 5x2 ml, R186,66  Warnings and special precautions: Usage not est. in depress.
                                                                  with psych. feat./bipol.disords./ endogen.depress., imp.ren./hepat.
       Lorazepam.                    Dosage: Admin.IVI slow. Compatibility: dil.with NaCl 0,9%, Gluc.5%   funct., pulm.dis., limit.pulm.reserv., depend.risk incr.with high.dos./
       Indications: Anx.disturbs., anx.assoc.with organ.dis.or adjustm.disturbs.  or Gluc.10%.  long term use & pts.prone to abuse drugs, avoid in psychot.pts.&
       (S5) TABS. U/2.6/38, 39.      Adults & juven: 2-20 mg IM/IV gen.recomm. depend. on body-  ment.depress.unless anx.mark., hypoman. & man.report.with use
       771759-002: 1 mg, 100, R155,76  weight/indicat.& sympt.severity.   in depress., cross. placenta & excret.in breast milk, concom. nefazo-
       771767-005: 2,5 mg, 100, R479,36  Premedicat: 10 mg IM. Childr: 0,1-0,2 mg/kg bodyweight 1 hr   done/fluvoxamine/cimetidine, co-admin. with fluoxetine/ OC’s/sertra-
       Dosage: Anx: 2-3 mg dly.admin.in 2-4 div.dos. this may range betw.1-  bef.anaesthes.induct.  line/diltiazem & macrolide antibiot., withdr.sympts.with rapid decr./
       6 mg dly. Elderly & debilitat: 1-2 mg/day in 2-4 div.dos.  Conscious sedat: 10 mg IM. Childr: 0,1-0,2 mg/ kg bodyweight.   abrupt discont., epilep., suicid.ideat., per. pt.re-assessm.
       Contraindications: Pre-exist.CNS depress., coma, porphyr., childr.  Indiv.dos.accord.to pt needs consists of init.inj.of 5 mg or 0,1 mg/kg   Drug interactions: Eliminat.delay. with ketoconazole/antiretrovir.
       und.12 yrs.                   bodyweight in childr.follow.every 30 sec.by increm. of 50% of init.dos.  protease inhibits., addit. eff.with CNS depress.incl.alcoh., incr.
       Side effects: Drowsin., oversedat., dizzin., weakn., unsteadin., con-  Eclampsia: Act./threaten.convuls: 10-20 mg IV. Addit.dos.as reqd.  plasma conc. of imipramine & desipramine, cert.hepat.enzym.
       fus., lethargy, vertigo, light headed., ment.depress., slurr.speech, libido   either IV/contin.infus.upto 100 mg/24 hrs.  inhibit.partic.P450IIIA4 incr.conc.
       changes, atax., trem., urin. retent./incontin., salivat. changes, jaund.,   Tetanus: 0,1-0,3 mg/kg bodyweight IV 1-4 hrly. Alternat.by contin.  See also MDR page 670.
       resp.depress., hypotens., GI disturbs., headache, sleep disturbs.,   infus./gastric tube: 3-4 mg/kg bodyweight in 24 hrs.
       agitat., skin rash, blurr.vis., amnes., memory impair., bld. disords.,   Status epileptic: Anticonvuls.eff: 0,15-0,25 mg/ kg bodyweight   ZOPAX, Cipla Medpro [P/S]
       paradoxic.reacts., tol.& depend., withdr. sympts.with abrupt withdr.  IV rep.as necess.aft.10-15 mins./by contin.infus. Max.dos: 3 mg/  Alprazolam.
       Special precautions: Psychot.pts., ment. depress., suicide.tenden.,   kg bodyweight in 24 hrs.  Indications: Anx.disords.& anx.assoc.with depress., panic disords
       epilept., tartraz.sensitiv., period.bld.counts & LFT elderly/debilitat.,   Excitat.states: Init.0,1-0,2 mg/kg bodyweight IV rep.at 8 hrly interv.  for up to 8 mnths.
       pulm. dis.& limit.pulm.reserve, ac.narr.angle glauc., ren./ hepat.dys-  until ac.sympts.subside thereaft. oral ther.  (S5) TABS. 30/2.6/0264, 0357, 0358.
       funct., pref.to avoid in pregn., cross. placenta, excret.in breast milk,   Contra-indications: Sev.resp.& hepat.insuffic., sleep apnoea syndr.,   826685-013: 0,25 mg, 100, R84,88
       abuse potent., alcoh. & drug abuse/hist.thereof, grad.withdr.,cont.lact.  myasthen.grav., prim. psychot. illn., alone in depress/anx.assoc.with   826693-016: 0,5 mg, 100, R118,82
       Drug interactions: Addit.CNS effs.with CNS depress.  depress., safety in pregn.not est.with incr. congenit.malformat.risk   826707-017: 1 mg, 100, R219,73
                                                                  Dosage: Indiv.using gen.principle of low. effect. dos. Overall treatm.
                                     with 1  trimest.use suggest., lactat., lactose intol.for tabs.
                                       st
       TRANXENE, Sanofi-Aventis [P/S]  Side-effects: Paradoxic.reacts., anterograde amnes., abuse & de-  should not exceed 8-12 wks. incl.a tapering off period. Max.dos.of
       Dipotassium clorazepate.      pend. & withdr.sympts.with abrupt.discont., rebound anx.on withdr.,   4 mg should not be exceed.except in panic disords.
       Indications: Sev./disabl./stressful anx.  withdr. sympts.in newborn infts., fatig., drowsin., musc. weakn., con-  Anx: Init. 0,25-0,5 mg 3xdly, usual dos.range: 0,5-4 mg dly.in div.dos.
       (S5) CAPS. F/2.6/167          fus., numb.emot., depress., reduc. alertn., incr./decr.libido, headache,   Depress.assoc.with anx: Init: 0,5 mg 3xdly. usual dos.range: 1,5-
       771694-008: 15 mg, 30, R263,52  atax., dizzin., hypersalivat., slurr.speech, dysarthr., trem., card. fail.incl.  4 mg dly.in div.dos.
       Dosage: Start with low.recomm.dos. re-assess.pt.reg.to keep treatm.  card.arrest, hypotens., pulse rate variat., circulat.& resp.depress., CV   Geriatr.pts./debilitat: Init: 0,25 mg 2-3xdly.
       as short as poss. Overall durat.of treatm.not to exceed 8-12 wks.incl.  collapse, diplop., blurr.vis., GI disturbs., hepato-bil.disords., incontin.,   Usual dos.range: 0,5-0,75 mg dly.in div.dos. incr.grad.if necess.& toler.
       taper.off period. Adults: 1 cap at bedtime.  urin.retent., incr.risk of falls & fract.in elderly, loc.reacts.with inj.  Panic attacks. Init: 0,5-1,0 mg at bedt. Adjust accord.to pt.respons
       Contra indications: Depress., pre-exist.CNS depress., coma,   Special precautions: CNS depress.depend.incl. alcoh.except.in   in increm.of no greater than 1 mg every 3-14 days. Addit.doses may
       ac.pulm.insuffic., sleep apnoea, prim.treatm.of psychot. illn.,   ac.withdr.reacts., re-eval.need.for cont. ther.reg., concom.alcoh./  be added until 3-4xdly sched.achiev.
       pregn.& lactat.               CNS depress., alcoh. / drug abuse hist., elderly, debilit., tol.aft.re-  Contraindications: Pregn., lactat., ac.narr.angle glauc., schizophren.,
       Side-effects: CNS effs., floppy inft.syndr.if giv. dur. labour., antero-  peat. use for prolong.period, paed.pts.bel.6 mnths.& only when alt.  chron.psychos., ment. depress. / suicide.tendenc.unless there is mark.
       grade amnes., musc.weakn., vertigo, trem., headache, asthen., chang.  not avail., myasth.grav., incr.freq.& sev.of grand mal epilep. attacks.  anx., pre-exist.CNS depress./coma, ac.pulm. insuffic., sleep apnoea,
       in salivat., libido chang., slurr.speech/dysarthr., paradox. reacts., ment.  dur.treatm./abrupt withdr., grad.withdr., use dur.labour & deliv., pass-  myasth.grav., porphyr., childr.
       depress., confus., hallucinat., hypersens. reacts., maculopapul.skin   es into breast milk, imp.hepat./ren.funct., anx. with underly. depress.   Side effects: CNS eff., vertigo, headache, dysarthria, libido chang.,
       rash, vis.disturbs., GI disturbs., resp.depress., hypotens., urin.retent./  disords.,obstruct.airway dis., arterioscleros.  tremor, vis.disturbs., urin. retent./ incontin., GI disturbs., salivat.
       incont., jaund., bld.disords.  Drug interactions: Enhanc.act.of other CNS depress., incr./prolong.  chang. jaund., bld.disords., hypersens.reacts., resp. depress. & hy-
       Special precautions: Incr withdr. syndr.risk.  with combinat.of other   sedat.by CYP3A &/CYP2C19 inhibit., metabol.eliminat.of phenytoin   potens.with high dos.
       benzodiaz.prescrib.as anxiolyt./ hypnot., alcoh./drug depend., elderly,   affect., incr. sedat.effs.with cisapride  Special precautions: Chron.pulm.insuffic., abuse & depend.
       debilit., resp.fail,, imp.hepat./ren.funct., pulm.dis., anx.accompan.by   potent., poss.withdraw./rebound phenomena, elderly/debilit.pts.,
       underly.depress. disord., where drop in BP may lead to card.compli-  XANOR, Pfizer [P/S] &  imp.ren./liv. funct., poss.suicide precipitat.if used alone to treat
       cat., period. bld.counts & liv funct.test with prolong treatm., do not   Alprazolam  depress./anx.with depress., withdr.slowly by no more than 0,5 mg
       use alone to treat. depress./anx.with depress.( poss.precipitat.of   Indications: Short term relief of anx.sympts., anx. disord.treatm.,   every 3 days esp.epilept.
       suicide.in such pts.), exacerb. myasthen.sympts., withdr.grad., poss.  anx.assoc.with depress., mix.anx.-depress., depress., panic disords.   Drug interactions: CNS depress.-addit.eff., plasma conc.of imipra-
       rebound phenomena.            Indicat.for up to 6 mnths for anx.& depress & up to 8 mnths for panic   mine & despiramne incr., clear. delay.by cimetidine/macrolide antibiot.
       Drug interactions: Eff.enhanc.by alcoh.& other CNS depress.,   disord.with/-out some phob.avoid.
       addit.synergy with neuromusc. depress., trans.incr.sedat.eff.due   (S5) TABS, [P/S] M/2.6/233, 234, 235, 27/2.6/96.
       to fast.absorpt. with cisapride, clozapine incr.risk of collapse with   778702-006: 0,25 mg, 30, R54,97
       resp./card.arrest.            778702-014: 0,25 mg, 100, R183,25  1.3.2  Others
       Warnings: Not for childr.und.12 yrs., poss.tol./ physic. depend., poss.  778710-009: 0,5 mg, 30, R94,54  STRESAM (MDR Listing)
       anterograde amnes.partic.if taken at bedt.& sleep durat.is short.  778710-017: 0,5 mg, 100, R315,17
                                     778729-001: 1 mg, 30, R179,97
       URBANOL, Sanofi-Aventis [P/S]  811696-006: 2 mg, 30, R343,53  BIRAL, (Mylan) Takeda [P/S]
                                                                  Valerianae extr.sicc. 100 mg, passiflorae extr.sicc. 45 mg.
       Clobazam.                     Dosage: Indiv.bas.on sympt.severity & pt.respons. When high.dos   Indications: Anx., restlessn., minor neuros. without depress.
       Indications: Anx.when sev.& disabl./subj.pt.to extreme stress, pre-  req.incr.even. dos. bef.dayt.dos. Use gen.principle of low.effect.dos.  (S0) TABS. B1503.
       op.medicat., alcoh.withdr. sympts.  in elderly/ debilit. Decr.dly. dos. by no more than 0,5 mg every 3 days.  708968-016: 20, R84,71
       (S5) TABS, [P/S] M/2.6/128.   Anx: Init. 0,25-0,5 mg 3xdly. Dos range: 0,5-4 mg dly.in div.dos.  708968-007: 40, R135,74
       773999-019: 10 mg, 100, R366,98  Mix.anx./depress., anx.assoc.with depress: Init: 0,5 mg 3xdly.   708968-015: 100, R326,60
       (S5) CAPS, [P/S] L/2.6/52.    Dos range: 1,5-4,5 mg dly in div.dos.  Dosage: 1-2 tabs 3xdly.aft.meals.
       774006-005: 5 mg, 100, R263,67  Panic disords: 0,5-1,0 mg at bedt.or 0,5 mg 3xdly., adjust.to
       Dosage: 10-30 mg dly in div.dos. Start with low. recomm.dos., not   pt.respons. Dos.increm.no great. than 1 mg every 3-4 days. Addit.  PASRIN, (Aspen Pharmacare: Pharma) Pharmacare [P/S]
       to exceed max.dos. Dos.of &gt; 20 mg admin.prefer.at bedt./in div.dos.  dos.can be added till a 3-4xdly sched.is achiev. Max.10 mg/day.  Buspirone HCl.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page39.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page35.html">35</a>&nbsp;&nbsp;&nbsp;<a href="page36.html">36</a>&nbsp;&nbsp;&nbsp;<a href="page37.html">37</a>&nbsp;&nbsp;&nbsp;<a href="page38.html">38</a>&nbsp;&nbsp;&nbsp;<a href="page39.html">39</a>&nbsp;&nbsp;&nbsp;<a href="page40.html">40</a>&nbsp;&nbsp;&nbsp;<a href="page41.html">41</a>&nbsp;&nbsp;&nbsp;<a href="page42.html">42</a>&nbsp;&nbsp;&nbsp;<a href="page43.html">43</a>&nbsp;&nbsp;&nbsp;<a href="page44.html">44</a>&nbsp;&nbsp;&nbsp;<a href="page45.html">45</a>
             </td>
             <td width="35%"><a href="page41.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page41.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
